IL-32 alpha, human recombinant

IL-32 alpha, human recombinant is available at Gentaur for Next week delivery.

A cytokine that induces immune cells to secrete TNF-α

Biomolecule/Target: IL-32 alpha

Alternates names: NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd, IL-32β, IL-32α, IL-32delta, IL-32γ, Interleukin-32, IL-32, Natural killer cells protein 4, Tumor necrosis factor α-inducing factor, IL-32a, IL32a, IL32, Interleukin-32 α.

Synonyms: NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd, IL-32β, IL-32α, IL-32delta, IL-32γ, Interleukin-32, IL-32, Natural killer cells protein 4, Tumor necrosis factor α-inducing factor, IL-32a, IL32a, IL32, Interleukin-32 α.

Background Information: Human IL-32 α is one of approximately 6 splice variants of a gene cloned from the human lung carcinoma stable transfectant, A549-Rβ. IL-32 α has been shown to induce IL-8, TNF-α, and MIP-2 production from human & mouse macrophage cell lines. It is up-regulated in activated T- & NK-cells, and IFN-γ-treated epithelial cells. Human recombinant IL-32 α produced in E. coli is a 131 amino acid non-glycosylated polypeptide with a molecular mass of 14.9 kDa.

Reconstitution Instructions: It is recommended to reconstitute the lyophilized product with sterile H₂O at a concentration of 0.1 mg/ml, which can be further diluted into other aqueous solutions.

NCBI Gene Symbol: IL32- α

Gene ID: 9235

NCBI Accession: P24001